文献速递心律失常血脂与心血管预防

中国东北地区心房颤动流行病学:2017-2019年横断面研究

Epidemiology of atrial fibrillation in northeast China: a cross-sectional study, 2017-2019.
PubMed 文献 · Heart · 2019-10-13

结果显示房颤总患病率为1.1%,男性高于女性,且随年龄增长急剧上升;房颤患者中90.2%需口服抗凝治疗但仅4.1%实际接受,高血压、血脂异常和糖尿病的控制率均很低。

要点

  • 东北地区≥40岁人群房颤患病率为1.1%,男性(1.5%)高于女性(0.9%),城乡无显著差异。
  • 房颤患者中90.2%有口服抗凝指征,但仅4.1%实际接受治疗。
  • 房颤患者高血压、血脂异常、糖尿病患病率高,但控制率分别仅7.0%、8.6%、28.8%。

核心结论

  • 东北地区房颤疾病负担较重,口服抗凝治疗严重不足且合并症控制不佳,可能影响未来心血管结局。

主要发现

  • 房颤总患病率为1.1%,随年龄增长急剧上升;男性患病率1.5%高于女性0.9%(p<0.001),城乡患病率1.3% vs 1.1%差异无统计学意义(p=0.228)。
  • 房颤患者总体知晓率为52.6%,女性61.5%高于男性44.1%(p=0.011),城乡知晓率60.0% vs 49.0%差异无统计学意义(p=0.129)。
  • 根据CHA2DS2-VASc评分,90.2%(194/215)的房颤患者需要口服抗凝治疗,但仅4.1%实际接受。
  • 房颤患者中高血压患病率66.5%、血脂异常32.6%、糖尿病24.2%,控制率分别为7.0%、8.6%、28.8%。

关键数值与推荐

  • 房颤诊断依据病史和心电图发现。
  • 口服抗凝治疗指征依据CHA2DS2-VASc评分,90.2%(194/215)的房颤患者需要口服抗凝治疗。

临床怎么用

  • 在东北地区≥40岁人群中应加强房颤筛查,尤其关注老年和男性人群。
  • 对房颤患者应评估CHA2DS2-VASc评分并规范启动口服抗凝治疗,缩小治疗差距。
  • 应加强房颤患者高血压、血脂异常和糖尿病的长期管理以改善心血管结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the epidemiology of atrial fibrillation (AF) in northeast China. METHODS: This cross-sectional survey using a multistage, stratified and cluster random sampling method was conducted in Liaoning Province between September 2017 and March 2019. A total of 18 796 participants (28.9% urban, 71.1% rural) aged ≥40 years were included. All participants completed a questionnaire and underwent a physical examination and ECG. AF was diagnosed according to history and ECG findings. RESULTS: The overall AF prevalence was 1.1%; it increased steeply with age. AF was more prevalent in men than in women (1.5% vs 0.9%, p<0.001); however, the difference between urban and rural areas was not significant (1.3% vs 1.1%, p=0.228). Among the AF population, the overall AF awareness rate was 52.6%, higher in women than in men (61.5% vs 44.1%, p=0.011); however, the difference between areas was not statistically significant (60.0% vs 49.0%, p=0.129). According to the CHA2DS-VASc score, almost all (90.2%, 194/215) of our subjects required oral anticoagulant (OAC) therapy; however, only 4.1% actually received it. Moreover, hypertension (66.5%), dyslipidaemia (32.6%) and diabetes (24.2%) were highly prevalent in patients with AF, but their control rates were unacceptably low (7.0%, 8.6% and 28.8%, respectively). CONCLUSIONS: The burden of AF in northeast China was substantial. Underuse of OAC therapy and uncontrolled comorbidities will likely contribute to the cardiovascular outcomes of patients with AF in the coming decades. Long-term management strategies for AF and related risk factors are required in northeast China.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Xing L, Lin M, Du Z, et al. Epidemiology of atrial fibrillation in northeast China: a cross-sectional study, 2017-2019. Heart. 2019. PMID: 31611327. doi:10.1136/heartjnl-2019-315397

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。